Child MalnutritionNCT02257762
Efficacy of a Multiple Micronutrient-Fortified Lipid-Based Nutrient Supplement for Children Under Two in Cambodia
A study testing LNS, Corn-soy blend ++ (CSB++) and Sprinkles in people with Child Malnutrition, run by Institut de Recherche pour le Developpement, Cambodia at 1 site in Cambodia.
Trial summary
The purpose of this trial is to evaluate the efficacy of the LNS on children aged 6-17 months in preventing growth faltering and improving micronutrient status. The impact of product will be compared to Corn Soy Blend ++ (CSB++), Sprinkles, and to a control group consuming an unsupplemented diet, which is usually… Read more about this study
- Who is it for?
- Ages 6 to 12 monthsHealthy volunteers can take part
- Conditions the study is for
- Child Malnutrition
- What is being tested?
- LNS, Corn-soy blend ++ (CSB++) and Sprinkles
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 487 participants
- Where
- 1 siteCambodia
- Study dates
- Feb 2016to Oct 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 12 months
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- Children aged 6-12 months
- Normally nourished or only moderately malnourished (MUAC>115mm, WHZ score>-3)
- Have not received therapy for acute malnutrition within one month prior to presentation
- Healthy (no ill-health in past two weeks)
- Anaemia status - normal, mild or moderate
- No known food intolerances
- Informed signed consent of caregiver
- Caregivers are healthy
Who cannot join
- Children <6 months or >12mths
- Severely malnourished (MUAC< 115mm, WHZ score<3, bipedal pitting oedema).
- Have received therapy for acute malnutrition within one month prior to presentation
- Any medical complications at the recruitment time or illness requiring referral or clinic visit in past 2 weeks
- Severe anaemia (Hb<70g/l)
- Known intolerances
- No informed signed consent of caregiver
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Efficacy of a Locally-Produced Multiple Micronutrient-Fortified Lipid-Based Nutrient Supplement (LNS) for Children Under Two Years in Cambodia
The purpose of this trial is to evaluate the efficacy of the LNS on children aged 6-17 months in preventing growth faltering and improving micronutrient status. The impact of product will be compared to Corn Soy Blend ++ (CSB++), Sprinkles, and to a control group consuming an unsupplemented diet, which is usually borbor at an early age, and thereafter, family foods.
Read the detailed description
BACKGROUND:
In Cambodia, progress in combatting malnutrition has stalled. In 2010, 40% of all children under five (and 49% of 4-5 year-olds) were stunted, 11% were wasted, and 28% were underweight, indicating, respectively, chronic and acute malnutrition, and a combination of the two. Stunting is partially attributed to poor complementary feeding, which remains inadequate for achieving growth outcomes and micronutrient status.
Malnutrition can be prevented with supplementary foods. These foods usually contain a source of protein and lipids such as powered milk, soy or peanuts, and multiple micronutrients. They can be prepared as a fortified blended product, such as Corn-Soy Blend++ (CSB++), that is mixed with water to make a porridge, or ready-to-use supplementary foods (RUSFs). The latter are usually lipid-based nutrient supplements (LNSs) which are often pastes such as the peanut-based Plumpy'Nut™. These energy-dense supplementary foods contain both macro and micronutrients and are used to prevent and treat moderate acute malnutrition by promoting improved linear growth, weight gain and micronutrient status among children. Until recently, treatment of moderate acute malnutrition has relied on fortified blended products. The new RUSFs are also proving effective, as they are higher energy and have a longer shelf life, and since they require no preparation, are convenient. Another common nutrition intervention is multiple micronutrient supplements such as Sprinkles. These are individually-packed powders that can be added to food. However, micronutrients are more likely to achieve growth outcomes when they are combined with energy, for example, in lipid-based nutrient supplements and there is no evidence that micronutrient powders alone contribute to growth.
Until June 2014, the United Nations World Food Program (WFP) used CSB++ (now called Supercereal Plus) to treat and prevent moderate acute malnutrition in Cambodia. Sprinkles are also being distributed, though not widely, to prevent micronutrient deficiencies. These products that have been recently or are currently used are relatively expensive to procure and ship to Cambodia and in the case of Sprinkles, are not as effective as foods that contain macronutrients. Moreover, CSB++ was not very well accepted in practice, and WFP has phased it out. Therefore, UNICEF and the Cambodian Ministry of Health are looking for a locally-produced product containing macro and micronutrients to prevent growth faltering and improve micronutrient status in Cambodian children.
TRIAL DESIGN AND METHODOLOGY:
Therefore, this trial will evaluate the efficacy of the LNS on children aged 6-17 months in preventing growth faltering and improving micronutrient statu. The impact of product will be compared to CSB++, Sprinkles, and to a control group.
The trial is a prospective, cluster randomised, non-blinded controlled trial among infants 6-17 months of age. The trial aims to establish the superiority of the novel LNS, using CSB++ and Sprinkles as active comparators and the unimproved diet as a control. The allocation ratio is 1:1. The study will take place over 8 months.
The study will be conducted in 28 sites in peri-urban Phnom Penh. Infants aged 6-12 months will be recruited. Upon consent and enrolment, baseline data will be collected from the participants. This will include demographics, morbidity, anthropometry (weight, height, mid-upper arm circumference, skinfolds), haematological and stool samples, dietary data (breastfeeding, food frequency and dietary diversity). Data will be collected monthly, and haematological samples will be collected again at endline.
Participants will then be provided with a one month supply of the food to which their site has been allocated. Staff will explain how to prepare the food, how often it should be consumed, and who should consume it (i.e. subjects). Participants will be provided with food on a monthly basis. They will continue to consume the food over a six-month period, at which time endline data, including haematological samples, will be collected.
- Conditions
- Child Malnutrition
- Being tested
- LNS, Corn-soy blend ++ (CSB++), Sprinkles
- Keywords
- Ready-to-use supplementary food (RUSF), Lipid-based nutrient supplement (LNS), Multiple micronutrients (MMN), Complementary feeding, Home fortification, Efficacy/impact, Infant and young child feeding (IYCF), Cambodia, Cluster randomised controlled trial
- Medical subject headings
- Child Nutrition Disorders, Tooth, Impacted
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
LNSDietary supplement
Compact, paste-filled wafer snack containing fish, rice, soy, mungbeans, oil, sugar and multiple micronutrients
Corn-soy blend ++ (CSB++)Dietary supplement
Also called Supercereal Plus
Blended flour containing soy, corn, milk powder, oil, sugar and multiple micronutrients.
SprinklesDietary supplement
Multiple micronutrient powder packaged in sachet.
| Study group | Role | What they receive |
|---|---|---|
| Lipid-based nutrient supplement (LNS) | Experimental | LNS added to borbor, eaten over 6 months, age 6-12 months to age 11-17 months Receives: Dietary Supplement: LNS |
| Corn-soy blend ++ (CSB++) | Active comparator | CSB++ porridge, eaten over 6 months, age 6-12 months to age 11-17 months Receives: Dietary Supplement: Corn-soy blend ++ (CSB++) |
| Sprinkles | Active comparator | Sprinkles added to borbor, eaten over 6 months, age 6-12 months to age 11-17 months Receives: Dietary Supplement: Sprinkles |
| Control | No intervention | Plain borbor and thereafter family foods, eaten over 6 months, age 6-12 months to age 11-17 months |
What is being measured
The primary outcome is the main question the study is designed to answer.
Nutritional status
Weight-for-height (WHZ), length/height-for-age (L/HAZ), and weight-for-age (WAZ) calculated through monthly weight and height measurements
Measured: 6 months
Secondary outcomes (2)
Body composition
Triceps, biceps and/or subscapular skinfolds
Measured: 6 months
Iron status
Analysis of haemoglobin (g/l), ferritin (µg/l), tranferrin receptor (mg/l), C reactive protein (mg/l), and alpha-1-acid glycoprotein (mg/l)
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Oct 2014 (estimated)
- Study startFeb 2016
- Primary completionOct 2016 (estimated)
- Study completionOct 2016 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Child MalnutritionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 487 participants (actual)
Sponsor and investigators
- Lead sponsor
- Institut de Recherche pour le Developpement, Cambodia
- Sponsor type
- Other government
- Collaborators
- UNICEF, Department of Fisheries Post-harvest Technologies and Quality Control
- Responsible party
- Principal investigator, Bindi Borg, University of Sydney
- Investigators
- Frank T Wieringa, MD, PhD, Study director, IRDBindi Borg, MA,PhD cand., Principal investigator, University of Sydney
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02257762
- Sponsor's protocol ID
- LNS-CAMB-INFANTS-EFF
- Status last verified
- Sep 2016
- First submitted
- 2 Oct 2014
- Last updated
- 15 Sep 2016
- Results posted
- No
- Data monitoring committee
- No
Publications
Borg B, Sok D, Mihrshahi S, Griffin M, Chamnan C, Berger J, Laillou A, Roos N, Wieringa FT. Effectiveness of a locally produced ready-to-use supplementary food in preventing growth faltering for children under 2 years in Cambodia: a cluster randomised controlled trial. Matern Child Nutr. 2020 Jan;16(1):e12896. doi: 10.1111/mcn.12896.
PubMed 31885221Borg B, Mihrshahi S, Griffin M, Sok D, Chhoun C, Laillou A, Berger J, Wieringa FT. Randomised controlled trial to test the effectiveness of a locally-produced ready-to-use supplementary food (RUSF) in preventing growth faltering and improving micronutrient status for children under two years in Cambodia: a study protocol. Nutr J. 2018 Mar 16;17(1):39. doi: 10.1186/s12937-018-0346-x.
PubMed 29548287
Study at a glance
From the registry record, last updated by the sponsor on 15 Sep 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Efficacy of a Locally-Produced Multiple Micronutrient-Fortified Lipid-Based Nutrient Supplement (LNS) for Children Under Two Years in Cambodia
- ClinicalTrials.gov ID
- NCT02257762
- Acronym / sponsor ID
- LNS-CAMB-INFANTS-EFF
- Conditions
- Child Malnutrition
- Keywords
- Ready-to-use supplementary food (RUSF), Lipid-based nutrient supplement (LNS), Multiple micronutrients (MMN), Complementary feeding, Home fortification, Efficacy/impact, Infant and young child feeding (IYCF), Cambodia
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 487 participants (actual)
- Lead sponsor
- Institut de Recherche pour le Developpement, CambodiaOther government
- Collaborators
- UNICEF, Department of Fisheries Post-harvest Technologies and Quality Control
- Study start
- Feb 2016
- Primary completion
- Oct 2016 (estimated)
- Study completion
- Oct 2016 (estimated)
- First posted
- 6 Oct 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this trial is to evaluate the efficacy of the LNS on children aged 6-17 months in preventing growth faltering and improving micronutrient status. The impact of product will be compared to Corn Soy Blend ++ (CSB++), Sprinkles, and to a control group consuming an unsupplemented diet, which is usually borbor at an early age, and thereafter, family foods.
Detailed description
BACKGROUND:
In Cambodia, progress in combatting malnutrition has stalled. In 2010, 40% of all children under five (and 49% of 4-5 year-olds) were stunted, 11% were wasted, and 28% were underweight, indicating, respectively, chronic and acute malnutrition, and a combination of the two. Stunting is partially attributed to poor complementary feeding, which remains inadequate for achieving growth outcomes and micronutrient status.
Malnutrition can be prevented with supplementary foods. These foods usually contain a source of protein and lipids such as powered milk, soy or peanuts, and multiple micronutrients. They can be prepared as a fortified blended product, such as Corn-Soy Blend++ (CSB++), that is mixed with water to make a porridge, or ready-to-use supplementary foods (RUSFs). The latter are usually lipid-based nutrient supplements (LNSs) which are often pastes such as the peanut-based Plumpy'Nut™. These energy-dense supplementary foods contain both macro and micronutrients and are used to prevent and treat moderate acute malnutrition by promoting improved linear growth, weight gain and micronutrient status among children. Until recently, treatment of moderate acute malnutrition has relied on fortified blended products. The new RUSFs are also proving effective, as they are higher energy and have a longer shelf life, and since they require no preparation, are convenient. Another common nutrition intervention is multiple micronutrient supplements such as Sprinkles. These are individually-packed powders that can be added to food. However, micronutrients are more likely to achieve growth outcomes when they are combined with energy, for example, in lipid-based nutrient supplements and there is no evidence that micronutrient powders alone contribute to growth.
Until June 2014, the United Nations World Food Program (WFP) used CSB++ (now called Supercereal Plus) to treat and prevent moderate acute malnutrition in Cambodia. Sprinkles are also being distributed, though not widely, to prevent micronutrient deficiencies. These products that have been recently or are currently used are relatively expensive to procure and ship to Cambodia and in the case of Sprinkles, are not as effective as foods that contain macronutrients. Moreover, CSB++ was not very well accepted in practice, and WFP has phased it out. Therefore, UNICEF and the Cambodian Ministry of Health are looking for a locally-produced product containing macro and micronutrients to prevent growth faltering and improve micronutrient status in Cambodian children.
TRIAL DESIGN AND METHODOLOGY:
Therefore, this trial will evaluate the efficacy of the LNS on children aged 6-17 months in preventing growth faltering and improving micronutrient statu. The impact of product will be compared to CSB++, Sprinkles, and to a control group.
The trial is a prospective, cluster randomised, non-blinded controlled trial among infants 6-17 months of age. The trial aims to establish the superiority of the novel LNS, using CSB++ and Sprinkles as active comparators and the unimproved diet as a control. The allocation ratio is 1:1. The study will take place over 8 months.
The study will be conducted in 28 sites in peri-urban Phnom Penh. Infants aged 6-12 months will be recruited. Upon consent and enrolment, baseline data will be collected from the participants. This will include demographics, morbidity, anthropometry (weight, height, mid-upper arm circumference, skinfolds), haematological and stool samples, dietary data (breastfeeding, food frequency and dietary diversity). Data will be collected monthly, and haematological samples will be collected again at endline.
Participants will then be provided with a one month supply of the food to which their site has been allocated. Staff will explain how to prepare the food, how often it should be consumed, and who should consume it (i.e. subjects). Participants will be provided with food on a monthly basis. They will continue to consume the food over a six-month period, at which time endline data, including haematological samples, will be collected.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Lipid-based nutrient supplement (LNS) | Experimental | Dietary Supplement: LNSLNS added to borbor, eaten over 6 months, age 6-12 months to age 11-17 months |
| Corn-soy blend ++ (CSB++) | Active comparator | Dietary Supplement: Corn-soy blend ++ (CSB++)CSB++ porridge, eaten over 6 months, age 6-12 months to age 11-17 months |
| Sprinkles | Active comparator | Dietary Supplement: SprinklesSprinkles added to borbor, eaten over 6 months, age 6-12 months to age 11-17 months |
| Control | No intervention | –Plain borbor and thereafter family foods, eaten over 6 months, age 6-12 months to age 11-17 months |
Who may qualify
- Ages
- 6 to 12 months
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (8 listed)
- Children aged 6-12 months
- Normally nourished or only moderately malnourished (MUAC>115mm, WHZ score>-3)
- Have not received therapy for acute malnutrition within one month prior to presentation
- Healthy (no ill-health in past two weeks)
- Anaemia status - normal, mild or moderate
Key exclusion criteria (7 listed)
- Children <6 months or >12mths
- Severely malnourished (MUAC< 115mm, WHZ score<3, bipedal pitting oedema).
- Have received therapy for acute malnutrition within one month prior to presentation
- Any medical complications at the recruitment time or illness requiring referral or clinic visit in past 2 weeks
- Severe anaemia (Hb<70g/l)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| LNSCompact, paste-filled wafer snack containing fish, rice, soy, mungbeans, oil, sugar and multiple micronutrients | Dietary supplement | Lipid-based nutrient supplement (LNS) |
| Corn-soy blend ++ (CSB++)Also: Supercereal PlusBlended flour containing soy, corn, milk powder, oil, sugar and multiple micronutrients. | Dietary supplement | Corn-soy blend ++ (CSB++) |
| SprinklesMultiple micronutrient powder packaged in sachet. | Dietary supplement | Sprinkles |
Primary outcome
Nutritional status
Time frame: 6 months
Weight-for-height (WHZ), length/height-for-age (L/HAZ), and weight-for-age (WAZ) calculated through monthly weight and height measurements
2 secondary outcomes
Body composition
Time frame: 6 months
Iron status
Time frame: 6 months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Sep 2016.
- Derived from this study: PubMed 31885221Borg B, Sok D, Mihrshahi S, Griffin M, Chamnan C, Berger J, Laillou A, Roos N, Wieringa FT. Effectiveness of a locally produced ready-to-use supplementary food in preventing growth faltering for children under 2 years in Cambodia: a cluster randomised controlled trial. Matern Child Nutr. 2020 Jan;16(1):e12896. doi: 10.1111/mcn.12896.
- Derived from this study: PubMed 29548287Borg B, Mihrshahi S, Griffin M, Sok D, Chhoun C, Laillou A, Berger J, Wieringa FT. Randomised controlled trial to test the effectiveness of a locally-produced ready-to-use supplementary food (RUSF) in preventing growth faltering and improving micronutrient status for children under two years in Cambodia: a study protocol. Nutr J. 2018 Mar 16;17(1):39. doi: 10.1186/s12937-018-0346-x.
Related trials for Child Malnutrition
Active, not recruitingPhase 2
Maternal Probiotic Intervention to Improve Gut Health-Trial II-Pakistan
Environmental Enteric Dysfunction (EED), Stunting
Recruiting
Role of Vitamin D Supplementation in Children With Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS), Vitamin D Deficiency
Active, not recruiting
Milk Fat Globule Membrane-Enhanced RUTF for Children With Severe Acute Malnutrition
Severe Acute Malnutrition, Cognitive Impairment
Active, not recruitingPhase 2
Comparative Efficacy of Antibiotics for Small Intestine Bacterial Overgrowth in Bangladeshi Children
Small Intestine Bacterial Overgrowth
Recruiting
Effectiveness of an Alternative Protocol in the Management of Acute Malnutrition
Acute Malnutrition With no Complications
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Frank T Wieringa, MD, PhD study director
IRD
Bindi Borg, MA,PhD cand. principal investigator
University of Sydney
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing LNS, Corn-soy blend ++ (CSB++) and Sprinkles in people with Child Malnutrition, run by Institut de Recherche pour le Developpement, Cambodia at 1 site in Cambodia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 15 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Cambodia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Nutritional status (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02257762, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2016.